Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...

Earnings call Dr. Lal PathLabs reported Q2 FY26 revenue of ₹731 crore, up 10.7% YoY, with PAT rising 16.4% to ₹152 crore. EBITDA margin held strong at 30.7%. Management reaffirmed FY26 revenue growth ...

New Delhi: The Delhi State Consumer Disputes Redressal Commission has upheld a finding on Dr Lal Pathlabs being deficient in service and ordering it pay compensation to a patient over a wrong lab ...

Dr Lal PathLabs, one of the largest lab testing companies in India, left a huge cache of patient data on a public server for months, TechCrunch has learned. The lab testing giant, headquartered in New ...

BENGALURU (Reuters) - Dr. Lal PathLabs, India's biggest diagnostics firm by revenue, posted a higher profit for the third straight quarter on Thursday, due to more diagnostics and tests in the monsoon ...

Dr. Lal PathLabs Limited ( ($IN:LALPATHLAB) ) has issued an announcement. Dr. Lal PathLabs Limited has announced that it will issue bonus equity ...

The latest update is out from Dr. Lal PathLabs Limited ( (IN:LALPATHLAB) ).

Fresh controversy has erupted around Algerian Olympic gold medalist Imane Khelif after newly leaked lab documents suggest that the boxer is biologically male. According to The Telegraph report Khelif ...